#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Differences in atypical resting-state effective connectivity distinguish autism from schizophrenia Autism and schizophrenia share overlapping genetic etiology, common changes in brain structure and common cognitive deficits.
1-1	0-11	Differences	_
1-2	12-14	in	_
1-3	15-23	atypical	_
1-4	24-37	resting-state	_
1-5	38-47	effective	_
1-6	48-60	connectivity	_
1-7	61-72	distinguish	_
1-8	73-79	autism	_
1-9	80-84	from	_
1-10	85-98	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-11	99-105	Autism	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
1-12	106-109	and	_
1-13	110-123	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-14	124-129	share	_
1-15	130-141	overlapping	_
1-16	142-149	genetic	_
1-17	150-158	etiology	_
1-18	159-160	,	_
1-19	161-167	common	_
1-20	168-175	changes	_
1-21	176-178	in	_
1-22	179-184	brain	_
1-23	185-194	structure	_
1-24	195-198	and	_
1-25	199-205	common	_
1-26	206-215	cognitive	_
1-27	216-224	deficits	_
1-28	225-226	.	_

Text=A number of studies using resting state fMRI have shown that machine learning algorithms can distinguish between healthy controls and individuals diagnosed with either autism spectrum disorder or schizophrenia.
2-1	227-228	A	_
2-2	229-235	number	_
2-3	236-238	of	_
2-4	239-246	studies	_
2-5	247-252	using	_
2-6	253-260	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-7	261-266	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-8	267-271	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
2-9	272-276	have	_
2-10	277-282	shown	_
2-11	283-287	that	_
2-12	288-295	machine	_
2-13	296-304	learning	_
2-14	305-315	algorithms	_
2-15	316-319	can	_
2-16	320-331	distinguish	_
2-17	332-339	between	_
2-18	340-347	healthy	_
2-19	348-356	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
2-20	357-360	and	_
2-21	361-372	individuals	_
2-22	373-382	diagnosed	_
2-23	383-387	with	_
2-24	388-394	either	_
2-25	395-401	autism	_
2-26	402-410	spectrum	_
2-27	411-419	disorder	_
2-28	420-422	or	_
2-29	423-436	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-30	437-438	.	_

Text=However, it has not yet been determined whether machine learning algorithms can be used to distinguish between the two disorders.
3-1	439-446	However	_
3-2	447-448	,	_
3-3	449-451	it	_
3-4	452-455	has	_
3-5	456-459	not	_
3-6	460-463	yet	_
3-7	464-468	been	_
3-8	469-479	determined	_
3-9	480-487	whether	_
3-10	488-495	machine	_
3-11	496-504	learning	_
3-12	505-515	algorithms	_
3-13	516-519	can	_
3-14	520-522	be	_
3-15	523-527	used	_
3-16	528-530	to	_
3-17	531-542	distinguish	_
3-18	543-550	between	_
3-19	551-554	the	_
3-20	555-558	two	_
3-21	559-568	disorders	_
3-22	569-570	.	_

Text=Using a linear support vector machine, we identify features that are most diagnostic for each disorder and successfully use them to classify an independent cohort of subjects.
4-1	571-576	Using	_
4-2	577-578	a	_
4-3	579-585	linear	_
4-4	586-593	support	_
4-5	594-600	vector	_
4-6	601-608	machine	_
4-7	609-610	,	_
4-8	611-613	we	_
4-9	614-622	identify	_
4-10	623-631	features	_
4-11	632-636	that	_
4-12	637-640	are	_
4-13	641-645	most	_
4-14	646-656	diagnostic	_
4-15	657-660	for	_
4-16	661-665	each	_
4-17	666-674	disorder	_
4-18	675-678	and	_
4-19	679-691	successfully	_
4-20	692-695	use	_
4-21	696-700	them	_
4-22	701-703	to	_
4-23	704-712	classify	_
4-24	713-715	an	_
4-25	716-727	independent	_
4-26	728-734	cohort	_
4-27	735-737	of	_
4-28	738-746	subjects	_
4-29	747-748	.	_

Text=We find both common and divergent connectivity differences largely in the default mode network as well as in salience, and motor networks.
5-1	749-751	We	_
5-2	752-756	find	_
5-3	757-761	both	_
5-4	762-768	common	_
5-5	769-772	and	_
5-6	773-782	divergent	_
5-7	783-795	connectivity	_
5-8	796-807	differences	_
5-9	808-815	largely	_
5-10	816-818	in	_
5-11	819-822	the	_
5-12	823-830	default	_
5-13	831-835	mode	_
5-14	836-843	network	_
5-15	844-846	as	_
5-16	847-851	well	_
5-17	852-854	as	_
5-18	855-857	in	_
5-19	858-866	salience	_
5-20	867-868	,	_
5-21	869-872	and	_
5-22	873-878	motor	_
5-23	879-887	networks	_
5-24	888-889	.	_

Text=Using divergent connectivity differences, we are able to distinguish autistic subjects from those with schizophrenia.
6-1	890-895	Using	_
6-2	896-905	divergent	_
6-3	906-918	connectivity	_
6-4	919-930	differences	_
6-5	931-932	,	_
6-6	933-935	we	_
6-7	936-939	are	_
6-8	940-944	able	_
6-9	945-947	to	_
6-10	948-959	distinguish	_
6-11	960-968	autistic	_
6-12	969-977	subjects	_
6-13	978-982	from	_
6-14	983-988	those	_
6-15	989-993	with	_
6-16	994-1007	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-17	1008-1009	.	_

Text=Understanding the common and divergent connectivity changes associated with these disorders may provide a framework for understanding their shared cognitive deficits.
7-1	1010-1023	Understanding	_
7-2	1024-1027	the	_
7-3	1028-1034	common	_
7-4	1035-1038	and	_
7-5	1039-1048	divergent	_
7-6	1049-1061	connectivity	_
7-7	1062-1069	changes	_
7-8	1070-1080	associated	_
7-9	1081-1085	with	_
7-10	1086-1091	these	_
7-11	1092-1101	disorders	_
7-12	1102-1105	may	_
7-13	1106-1113	provide	_
7-14	1114-1115	a	_
7-15	1116-1125	framework	_
7-16	1126-1129	for	_
7-17	1130-1143	understanding	_
7-18	1144-1149	their	_
7-19	1150-1156	shared	_
7-20	1157-1166	cognitive	_
7-21	1167-1175	deficits	_
7-22	1176-1177	.	_

Text=Highlights Common and divergent diagnostic features for autism and schizophrenia are identified.
8-1	1178-1188	Highlights	_
8-2	1189-1195	Common	_
8-3	1196-1199	and	_
8-4	1200-1209	divergent	_
8-5	1210-1220	diagnostic	_
8-6	1221-1229	features	_
8-7	1230-1233	for	_
8-8	1234-1240	autism	http://maven.renci.org/NeuroBridge/neurobridge#AutismSpectrumDisorder
8-9	1241-1244	and	_
8-10	1245-1258	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
8-11	1259-1262	are	_
8-12	1263-1273	identified	_
8-13	1274-1275	.	_

Text=SVM classifiers successfully identify patients from training-naive patient groups.
9-1	1276-1279	SVM	_
9-2	1280-1291	classifiers	_
9-3	1292-1304	successfully	_
9-4	1305-1313	identify	_
9-5	1314-1322	patients	_
9-6	1323-1327	from	_
9-7	1328-1342	training-naive	_
9-8	1343-1350	patient	_
9-9	1351-1357	groups	_
9-10	1358-1359	.	_

Text=Diagnostic connectivity changes cluster in the default mode and salience networks.
10-1	1360-1370	Diagnostic	_
10-2	1371-1383	connectivity	_
10-3	1384-1391	changes	_
10-4	1392-1399	cluster	_
10-5	1400-1402	in	_
10-6	1403-1406	the	_
10-7	1407-1414	default	_
10-8	1415-1419	mode	_
10-9	1420-1423	and	_
10-10	1424-1432	salience	_
10-11	1433-1441	networks	_
10-12	1442-1443	.	_

Text=Shared diagnostic features predict deficits in communication skills in autism.
11-1	1444-1450	Shared	_
11-2	1451-1461	diagnostic	_
11-3	1462-1470	features	_
11-4	1471-1478	predict	_
11-5	1479-1487	deficits	_
11-6	1488-1490	in	_
11-7	1491-1504	communication	_
11-8	1505-1511	skills	_
11-9	1512-1514	in	_
11-10	1515-1521	autism	_
11-11	1522-1523	.	_

Text=Unique features distinguish autism and schizophrenic patients.
12-1	1524-1530	Unique	_
12-2	1531-1539	features	_
12-3	1540-1551	distinguish	_
12-4	1552-1558	autism	_
12-5	1559-1562	and	_
12-6	1563-1576	schizophrenic	_
12-7	1577-1585	patients	_
12-8	1586-1587	.	_

Text=Materials and methods Data Resting state data for subjects with SZ was archived by the Center for Biomedical Research Excellence (COBRE) and obtained from http: //fcon_1000.projects.nitrc.org/indi/retro/cobre.html.
13-1	1588-1597	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
13-2	1598-1601	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
13-3	1602-1609	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
13-4	1610-1614	Data	_
13-5	1615-1622	Resting	_
13-6	1623-1628	state	_
13-7	1629-1633	data	_
13-8	1634-1637	for	_
13-9	1638-1646	subjects	_
13-10	1647-1651	with	_
13-11	1652-1654	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
13-12	1655-1658	was	_
13-13	1659-1667	archived	_
13-14	1668-1670	by	_
13-15	1671-1674	the	_
13-16	1675-1681	Center	_
13-17	1682-1685	for	_
13-18	1686-1696	Biomedical	_
13-19	1697-1705	Research	_
13-20	1706-1716	Excellence	_
13-21	1717-1718	(	_
13-22	1719-1724	COBRE	_
13-23	1725-1726	)	_
13-24	1727-1730	and	_
13-25	1731-1739	obtained	_
13-26	1740-1744	from	_
13-27	1745-1749	http	_
13-28	1750-1751	:	_
13-29	1752-1804	//fcon_1000.projects.nitrc.org/indi/retro/cobre.html	_
13-30	1805-1806	.	_

Text=The data set included 146 subjects ranging in age between 18 and 65 (72 SZ mean age = 38.17; SD = 13.89; 58 males and 74 controls mean age = 35.82; SD = 11.58; 51 males).
14-1	1807-1810	The	_
14-2	1811-1815	data	_
14-3	1816-1819	set	_
14-4	1820-1828	included	_
14-5	1829-1832	146	_
14-6	1833-1841	subjects	_
14-7	1842-1849	ranging	_
14-8	1850-1852	in	_
14-9	1853-1856	age	_
14-10	1857-1864	between	_
14-11	1865-1867	18	_
14-12	1868-1871	and	_
14-13	1872-1874	65	_
14-14	1875-1876	(	_
14-15	1877-1879	72	_
14-16	1880-1882	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
14-17	1883-1887	mean	_
14-18	1888-1891	age	_
14-19	1892-1893	=	_
14-20	1894-1899	38.17	_
14-21	1900-1901	;	_
14-22	1902-1904	SD	_
14-23	1905-1906	=	_
14-24	1907-1912	13.89	_
14-25	1913-1914	;	_
14-26	1915-1917	58	_
14-27	1918-1923	males	_
14-28	1924-1927	and	_
14-29	1928-1930	74	_
14-30	1931-1939	controls	_
14-31	1940-1944	mean	_
14-32	1945-1948	age	_
14-33	1949-1950	=	_
14-34	1951-1956	35.82	_
14-35	1957-1958	;	_
14-36	1959-1961	SD	_
14-37	1962-1963	=	_
14-38	1964-1969	11.58	_
14-39	1970-1971	;	_
14-40	1972-1974	51	_
14-41	1975-1980	males	_
14-42	1981-1982	)	_
14-43	1983-1984	.	_

Text=This data set was used to train a support vector machine (SVM) classifier.
15-1	1985-1989	This	_
15-2	1990-1994	data	_
15-3	1995-1998	set	_
15-4	1999-2002	was	_
15-5	2003-2007	used	_
15-6	2008-2010	to	_
15-7	2011-2016	train	_
15-8	2017-2018	a	_
15-9	2019-2026	support	_
15-10	2027-2033	vector	_
15-11	2034-2041	machine	_
15-12	2042-2043	(	_
15-13	2044-2047	SVM	_
15-14	2048-2049	)	_
15-15	2050-2060	classifier	_
15-16	2061-2062	.	_

Text=A separate data set was used as a testing cross validation set.
16-1	2063-2064	A	_
16-2	2065-2073	separate	_
16-3	2074-2078	data	_
16-4	2079-2082	set	_
16-5	2083-2086	was	_
16-6	2087-2091	used	_
16-7	2092-2094	as	_
16-8	2095-2096	a	_
16-9	2097-2104	testing	_
16-10	2105-2110	cross	_
16-11	2111-2121	validation	_
16-12	2122-2125	set	_
16-13	2126-2127	.	_

Text=The classifier was never trained on the testing cross validation data sets.
17-1	2128-2131	The	_
17-2	2132-2142	classifier	_
17-3	2143-2146	was	_
17-4	2147-2152	never	_
17-5	2153-2160	trained	_
17-6	2161-2163	on	_
17-7	2164-2167	the	_
17-8	2168-2175	testing	_
17-9	2176-2181	cross	_
17-10	2182-2192	validation	_
17-11	2193-2197	data	_
17-12	2198-2202	sets	_
17-13	2203-2204	.	_

Text=Testing data was collected at the Rutgers University Brain Imaging Center as part of another study (not yet published).
18-1	2205-2212	Testing	_
18-2	2213-2217	data	_
18-3	2218-2221	was	_
18-4	2222-2231	collected	_
18-5	2232-2234	at	_
18-6	2235-2238	the	_
18-7	2239-2246	Rutgers	_
18-8	2247-2257	University	_
18-9	2258-2263	Brain	_
18-10	2264-2271	Imaging	_
18-11	2272-2278	Center	_
18-12	2279-2281	as	_
18-13	2282-2286	part	_
18-14	2287-2289	of	_
18-15	2290-2297	another	_
18-16	2298-2303	study	_
18-17	2304-2305	(	_
18-18	2306-2309	not	_
18-19	2310-2313	yet	_
18-20	2314-2323	published	_
18-21	2324-2325	)	_
18-22	2326-2327	.	_

Text=It included 10 subjects ranging in age from 19 to 54 years old (5 SZ mean age = 42.6; SD = 11.59; 2 males and 5 controls mean age = 20; SD = 1.22; 2 males) with two resting state scans each.
19-1	2328-2330	It	_
19-2	2331-2339	included	_
19-3	2340-2342	10	_
19-4	2343-2351	subjects	_
19-5	2352-2359	ranging	_
19-6	2360-2362	in	_
19-7	2363-2366	age	_
19-8	2367-2371	from	_
19-9	2372-2374	19	_
19-10	2375-2377	to	_
19-11	2378-2380	54	_
19-12	2381-2386	years	_
19-13	2387-2390	old	_
19-14	2391-2392	(	_
19-15	2393-2394	5	_
19-16	2395-2397	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
19-17	2398-2402	mean	_
19-18	2403-2406	age	_
19-19	2407-2408	=	_
19-20	2409-2413	42.6	_
19-21	2414-2415	;	_
19-22	2416-2418	SD	_
19-23	2419-2420	=	_
19-24	2421-2426	11.59	_
19-25	2427-2428	;	_
19-26	2429-2430	2	_
19-27	2431-2436	males	_
19-28	2437-2440	and	_
19-29	2441-2442	5	_
19-30	2443-2451	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-31	2452-2456	mean	_
19-32	2457-2460	age	_
19-33	2461-2462	=	_
19-34	2463-2465	20	_
19-35	2466-2467	;	_
19-36	2468-2470	SD	_
19-37	2471-2472	=	_
19-38	2473-2477	1.22	_
19-39	2478-2479	;	_
19-40	2480-2481	2	_
19-41	2482-2487	males	_
19-42	2488-2489	)	_
19-43	2490-2494	with	_
19-44	2495-2498	two	_
19-45	2499-2506	resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
19-46	2507-2512	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
19-47	2513-2518	scans	_
19-48	2519-2523	each	_
19-49	2524-2525	.	_

Text=Resting state data for autistic spectrum disorder subjects was archived by the Autism Brian Imaging Exchange (ABIDE) and obtained from http: //fcon_1000.projects.nitrc.org/indi/abide.
20-1	2526-2533	Resting	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
20-2	2534-2539	state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
20-3	2540-2544	data	_
20-4	2545-2548	for	_
20-5	2549-2557	autistic	http://maven.renci.org/NeuroBridge/neurobridge#AutisticDisorder
20-6	2558-2566	spectrum	http://maven.renci.org/NeuroBridge/neurobridge#AutisticDisorder
20-7	2567-2575	disorder	http://maven.renci.org/NeuroBridge/neurobridge#AutisticDisorder
20-8	2576-2584	subjects	http://maven.renci.org/NeuroBridge/neurobridge#AutisticDisorder
20-9	2585-2588	was	_
20-10	2589-2597	archived	_
20-11	2598-2600	by	_
20-12	2601-2604	the	_
20-13	2605-2611	Autism	_
20-14	2612-2617	Brian	http://maven.renci.org/NeuroBridge/neurobridge#Median
20-15	2618-2625	Imaging	_
20-16	2626-2634	Exchange	_
20-17	2635-2636	(	_
20-18	2637-2642	ABIDE	_
20-19	2643-2644	)	_
20-20	2645-2648	and	_
20-21	2649-2657	obtained	_
20-22	2658-2662	from	_
20-23	2663-2667	http	_
20-24	2668-2669	:	_
20-25	2670-2711	//fcon_1000.projects.nitrc.org/indi/abide	_
20-26	2712-2713	.	_

Text=We used the ABIDE I University of Utah School of Medicine (USM) data set.
21-1	2714-2716	We	_
21-2	2717-2721	used	_
21-3	2722-2725	the	_
21-4	2726-2731	ABIDE	_
21-5	2732-2733	I	_
21-6	2734-2744	University	_
21-7	2745-2747	of	_
21-8	2748-2752	Utah	_
21-9	2753-2759	School	_
21-10	2760-2762	of	_
21-11	2763-2771	Medicine	_
21-12	2772-2773	(	_
21-13	2774-2777	USM	_
21-14	2778-2779	)	_
21-15	2780-2784	data	_
21-16	2785-2788	set	_
21-17	2789-2790	.	_

Text=It consisted of 101 subjects between the ages of 8 and 50 (58 ASD 11–50 years old; mean = 22.65; SD = 7.73 and 43 controls 8–39 years old; mean = 21.36; SD = 7.64).
22-1	2791-2793	It	_
22-2	2794-2803	consisted	_
22-3	2804-2806	of	_
22-4	2807-2810	101	_
22-5	2811-2819	subjects	_
22-6	2820-2827	between	_
22-7	2828-2831	the	_
22-8	2832-2836	ages	_
22-9	2837-2839	of	_
22-10	2840-2841	8	_
22-11	2842-2845	and	_
22-12	2846-2848	50	_
22-13	2849-2850	(	_
22-14	2851-2853	58	_
22-15	2854-2857	ASD	http://maven.renci.org/NeuroBridge/neurobridge#Thing
22-16	2858-2863	11–50	_
22-17	2864-2869	years	_
22-18	2870-2873	old	_
22-19	2874-2875	;	_
22-20	2876-2880	mean	_
22-21	2881-2882	=	_
22-22	2883-2888	22.65	_
22-23	2889-2890	;	_
22-24	2891-2893	SD	_
22-25	2894-2895	=	_
22-26	2896-2900	7.73	_
22-27	2901-2904	and	_
22-28	2905-2907	43	_
22-29	2908-2916	controls	_
22-30	2917-2921	8–39	_
22-31	2922-2927	years	_
22-32	2928-2931	old	_
22-33	2932-2933	;	_
22-34	2934-2938	mean	_
22-35	2939-2940	=	_
22-36	2941-2946	21.36	_
22-37	2947-2948	;	_
22-38	2949-2951	SD	_
22-39	2952-2953	=	_
22-40	2954-2958	7.64	_
22-41	2959-2960	)	_
22-42	2961-2962	.	_

Text=As the COBRE data set did not include any individuals below 18 years of age, we excluded subjects below the age of 18 resulting in 37 patients (mean age = 26.34, SD = 7.37, 37 males) and 27 controls (mean age = 25.42, SD = 6.28, 27 males).
23-1	2963-2965	As	_
23-2	2966-2969	the	_
23-3	2970-2975	COBRE	_
23-4	2976-2980	data	_
23-5	2981-2984	set	_
23-6	2985-2988	did	_
23-7	2989-2992	not	_
23-8	2993-3000	include	_
23-9	3001-3004	any	_
23-10	3005-3016	individuals	_
23-11	3017-3022	below	_
23-12	3023-3025	18	_
23-13	3026-3031	years	_
23-14	3032-3034	of	_
23-15	3035-3038	age	_
23-16	3039-3040	,	_
23-17	3041-3043	we	_
23-18	3044-3052	excluded	_
23-19	3053-3061	subjects	_
23-20	3062-3067	below	_
23-21	3068-3071	the	_
23-22	3072-3075	age	_
23-23	3076-3078	of	_
23-24	3079-3081	18	_
23-25	3082-3091	resulting	_
23-26	3092-3094	in	_
23-27	3095-3097	37	_
23-28	3098-3106	patients	_
23-29	3107-3108	(	_
23-30	3109-3113	mean	_
23-31	3114-3117	age	_
23-32	3118-3119	=	_
23-33	3120-3125	26.34	_
23-34	3126-3127	,	_
23-35	3128-3130	SD	_
23-36	3131-3132	=	_
23-37	3133-3137	7.37	_
23-38	3138-3139	,	_
23-39	3140-3142	37	_
23-40	3143-3148	males	_
23-41	3149-3150	)	_
23-42	3151-3154	and	_
23-43	3155-3157	27	_
23-44	3158-3166	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
23-45	3167-3168	(	_
23-46	3169-3173	mean	_
23-47	3174-3177	age	_
23-48	3178-3179	=	_
23-49	3180-3185	25.42	_
23-50	3186-3187	,	_
23-51	3188-3190	SD	_
23-52	3191-3192	=	_
23-53	3193-3197	6.28	_
23-54	3198-3199	,	_
23-55	3200-3202	27	_
23-56	3203-3208	males	_
23-57	3209-3210	)	_
23-58	3211-3212	.	_

Text=Testing cross validation was performed on the ABIDE II Barrow Neurological Institute (BNI) data set.
24-1	3213-3220	Testing	_
24-2	3221-3226	cross	_
24-3	3227-3237	validation	_
24-4	3238-3241	was	_
24-5	3242-3251	performed	_
24-6	3252-3254	on	_
24-7	3255-3258	the	_
24-8	3259-3264	ABIDE	_
24-9	3265-3267	II	_
24-10	3268-3274	Barrow	_
24-11	3275-3287	Neurological	_
24-12	3288-3297	Institute	_
24-13	3298-3299	(	_
24-14	3300-3303	BNI	_
24-15	3304-3305	)	_
24-16	3306-3310	data	_
24-17	3311-3314	set	_
24-18	3315-3316	.	_

Text=It consisted of 58 subjects between the ages of 18 and 64 (29 controls 18–64; mean age = 39.59, SD = 15.09 and 29 patients 18–62; mean age = 37.44; SD = 16.09).
25-1	3317-3319	It	_
25-2	3320-3329	consisted	_
25-3	3330-3332	of	_
25-4	3333-3335	58	_
25-5	3336-3344	subjects	_
25-6	3345-3352	between	_
25-7	3353-3356	the	_
25-8	3357-3361	ages	_
25-9	3362-3364	of	_
25-10	3365-3367	18	_
25-11	3368-3371	and	_
25-12	3372-3374	64	_
25-13	3375-3376	(	_
25-14	3377-3379	29	_
25-15	3380-3388	controls	_
25-16	3389-3394	18–64	_
25-17	3395-3396	;	_
25-18	3397-3401	mean	_
25-19	3402-3405	age	_
25-20	3406-3407	=	_
25-21	3408-3413	39.59	_
25-22	3414-3415	,	_
25-23	3416-3418	SD	_
25-24	3419-3420	=	_
25-25	3421-3426	15.09	_
25-26	3427-3430	and	_
25-27	3431-3433	29	_
25-28	3434-3442	patients	_
25-29	3443-3448	18–62	_
25-30	3449-3450	;	_
25-31	3451-3455	mean	_
25-32	3456-3459	age	_
25-33	3460-3461	=	_
25-34	3462-3467	37.44	_
25-35	3468-3469	;	_
25-36	3470-3472	SD	_
25-37	3473-3474	=	_
25-38	3475-3480	16.09	_
25-39	3481-3482	)	_
25-40	3483-3484	.	_

Text=After removing four 18 year old subjects, our sample consisted of 27 controls (mean age = 39.58; SD = 15.09; 27 males) and 27 patients (mean age = 37.6; SD = 16.09; 27 males).
26-1	3485-3490	After	_
26-2	3491-3499	removing	_
26-3	3500-3504	four	_
26-4	3505-3507	18	_
26-5	3508-3512	year	_
26-6	3513-3516	old	_
26-7	3517-3525	subjects	_
26-8	3526-3527	,	_
26-9	3528-3531	our	_
26-10	3532-3538	sample	_
26-11	3539-3548	consisted	_
26-12	3549-3551	of	_
26-13	3552-3554	27	_
26-14	3555-3563	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
26-15	3564-3565	(	_
26-16	3566-3570	mean	_
26-17	3571-3574	age	_
26-18	3575-3576	=	_
26-19	3577-3582	39.58	_
26-20	3583-3584	;	_
26-21	3585-3587	SD	_
26-22	3588-3589	=	_
26-23	3590-3595	15.09	_
26-24	3596-3597	;	_
26-25	3598-3600	27	_
26-26	3601-3606	males	_
26-27	3607-3608	)	_
26-28	3609-3612	and	_
26-29	3613-3615	27	_
26-30	3616-3624	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
26-31	3625-3626	(	_
26-32	3627-3631	mean	_
26-33	3632-3635	age	_
26-34	3636-3637	=	_
26-35	3638-3642	37.6	_
26-36	3643-3644	;	_
26-37	3645-3647	SD	_
26-38	3648-3649	=	_
26-39	3650-3655	16.09	_
26-40	3656-3657	;	_
26-41	3658-3660	27	_
26-42	3661-3666	males	_
26-43	3667-3668	)	_
26-44	3669-3670	.	_

Text=All data was collected in compliance with their relevant institutional review boards.
27-1	3671-3674	All	_
27-2	3675-3679	data	_
27-3	3680-3683	was	_
27-4	3684-3693	collected	_
27-5	3694-3696	in	_
27-6	3697-3707	compliance	_
27-7	3708-3712	with	_
27-8	3713-3718	their	_
27-9	3719-3727	relevant	_
27-10	3728-3741	institutional	_
27-11	3742-3748	review	_
27-12	3749-3755	boards	_
27-13	3756-3757	.	_

Text=To identify common and disparate features and to use SVM to distinguish between SZ and ASD, we created a hybrid control group made up of subjects from each of the SZ and ASD control sets.
28-1	3758-3760	To	_
28-2	3761-3769	identify	_
28-3	3770-3776	common	_
28-4	3777-3780	and	_
28-5	3781-3790	disparate	_
28-6	3791-3799	features	_
28-7	3800-3803	and	_
28-8	3804-3806	to	_
28-9	3807-3810	use	_
28-10	3811-3814	SVM	_
28-11	3815-3817	to	_
28-12	3818-3829	distinguish	_
28-13	3830-3837	between	_
28-14	3838-3840	SZ	_
28-15	3841-3844	and	_
28-16	3845-3848	ASD	_
28-17	3849-3850	,	_
28-18	3851-3853	we	_
28-19	3854-3861	created	_
28-20	3862-3863	a	_
28-21	3864-3870	hybrid	_
28-22	3871-3878	control	_
28-23	3879-3884	group	_
28-24	3885-3889	made	_
28-25	3890-3892	up	_
28-26	3893-3895	of	_
28-27	3896-3904	subjects	_
28-28	3905-3909	from	_
28-29	3910-3914	each	_
28-30	3915-3917	of	_
28-31	3918-3921	the	_
28-32	3922-3924	SZ	_
28-33	3925-3928	and	_
28-34	3929-3932	ASD	_
28-35	3933-3940	control	_
28-36	3941-3945	sets	_
28-37	3946-3947	.	_

Text=The hybrid control group was constructed by combining the 27 ASD control subjects from the ASD training set with 27 randomly selected subjects from the control group of the SZ training data set.
29-1	3948-3951	The	_
29-2	3952-3958	hybrid	_
29-3	3959-3966	control	_
29-4	3967-3972	group	_
29-5	3973-3976	was	_
29-6	3977-3988	constructed	_
29-7	3989-3991	by	_
29-8	3992-4001	combining	_
29-9	4002-4005	the	_
29-10	4006-4008	27	_
29-11	4009-4012	ASD	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
29-12	4013-4020	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
29-13	4021-4029	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
29-14	4030-4034	from	_
29-15	4035-4038	the	_
29-16	4039-4042	ASD	http://maven.renci.org/NeuroBridge/neurobridge#Thing
29-17	4043-4051	training	_
29-18	4052-4055	set	_
29-19	4056-4060	with	_
29-20	4061-4063	27	_
29-21	4064-4072	randomly	_
29-22	4073-4081	selected	_
29-23	4082-4090	subjects	_
29-24	4091-4095	from	_
29-25	4096-4099	the	_
29-26	4100-4107	control	_
29-27	4108-4113	group	_
29-28	4114-4116	of	_
29-29	4117-4120	the	_
29-30	4121-4123	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
29-31	4124-4132	training	_
29-32	4133-4137	data	_
29-33	4138-4141	set	_
29-34	4142-4143	.	_

Text=The RFE procedure was then applied to identify features that distinguish SZ patients from the hybrid control group and ASD patients from the hybrid control group.
30-1	4144-4147	The	_
30-2	4148-4151	RFE	_
30-3	4152-4161	procedure	_
30-4	4162-4165	was	_
30-5	4166-4170	then	_
30-6	4171-4178	applied	_
30-7	4179-4181	to	_
30-8	4182-4190	identify	_
30-9	4191-4199	features	_
30-10	4200-4204	that	_
30-11	4205-4216	distinguish	_
30-12	4217-4219	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
30-13	4220-4228	patients	_
30-14	4229-4233	from	_
30-15	4234-4237	the	_
30-16	4238-4244	hybrid	_
30-17	4245-4252	control	_
30-18	4253-4258	group	_
30-19	4259-4262	and	_
30-20	4263-4266	ASD	http://maven.renci.org/NeuroBridge/neurobridge#Thing
30-21	4267-4275	patients	_
30-22	4276-4280	from	_
30-23	4281-4284	the	_
30-24	4285-4291	hybrid	_
30-25	4292-4299	control	_
30-26	4300-4305	group	_
30-27	4306-4307	.	_

Text=The ASD and SZ feature sets were then compared to identify common and disparate features of the two disorders.
31-1	4308-4311	The	_
31-2	4312-4315	ASD	http://maven.renci.org/NeuroBridge/neurobridge#Thing
31-3	4316-4319	and	_
31-4	4320-4322	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
31-5	4323-4330	feature	_
31-6	4331-4335	sets	_
31-7	4336-4340	were	_
31-8	4341-4345	then	_
31-9	4346-4354	compared	_
31-10	4355-4357	to	_
31-11	4358-4366	identify	_
31-12	4367-4373	common	_
31-13	4374-4377	and	_
31-14	4378-4387	disparate	_
31-15	4388-4396	features	_
31-16	4397-4399	of	_
31-17	4400-4403	the	_
31-18	4404-4407	two	_
31-19	4408-4417	disorders	_
31-20	4418-4419	.	_

Text=Preprocessing Preprocessing steps were carried out using FSL (http: //fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL) and included brain extraction using FSL's BET, motion correction using FSL's MCFLIRT, and linear registration to the Montreal Neurological Institute (MNI152) 2mm standard using FSL's FLIRT.
32-1	4420-4433	Preprocessing	_
32-2	4434-4447	Preprocessing	_
32-3	4448-4453	steps	_
32-4	4454-4458	were	_
32-5	4459-4466	carried	_
32-6	4467-4470	out	_
32-7	4471-4476	using	_
32-8	4477-4480	FSL	_
32-9	4481-4482	(	_
32-10	4483-4487	http	_
32-11	4488-4489	:	_
32-12	4490-4526	//fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL	_
32-13	4527-4528	)	_
32-14	4529-4532	and	_
32-15	4533-4541	included	_
32-16	4542-4547	brain	_
32-17	4548-4558	extraction	_
32-18	4559-4564	using	_
32-19	4565-4568	FSL	_
32-20	4569-4571	's	_
32-21	4572-4575	BET	_
32-22	4576-4577	,	_
32-23	4578-4584	motion	_
32-24	4585-4595	correction	_
32-25	4596-4601	using	_
32-26	4602-4605	FSL	_
32-27	4606-4608	's	_
32-28	4609-4616	MCFLIRT	_
32-29	4617-4618	,	_
32-30	4619-4622	and	_
32-31	4623-4629	linear	_
32-32	4630-4642	registration	_
32-33	4643-4645	to	_
32-34	4646-4649	the	_
32-35	4650-4658	Montreal	_
32-36	4659-4671	Neurological	_
32-37	4672-4681	Institute	_
32-38	4682-4683	(	_
32-39	4684-4690	MNI152	_
32-40	4691-4692	)	_
32-41	4693-4696	2mm	_
32-42	4697-4705	standard	_
32-43	4706-4711	using	_
32-44	4712-4715	FSL	_
32-45	4716-4718	's	_
32-46	4719-4724	FLIRT	_
32-47	4725-4726	.	_

Text=Frame displacement parameters were regressed out of each data set to control for motion.
33-1	4727-4732	Frame	_
33-2	4733-4745	displacement	_
33-3	4746-4756	parameters	_
33-4	4757-4761	were	_
33-5	4762-4771	regressed	_
33-6	4772-4775	out	_
33-7	4776-4778	of	_
33-8	4779-4783	each	_
33-9	4784-4788	data	_
33-10	4789-4792	set	_
33-11	4793-4795	to	_
33-12	4796-4803	control	_
33-13	4804-4807	for	_
33-14	4808-4814	motion	_
33-15	4815-4816	.	_

Text=ROI selection We chose to use a set of 283 regions of interest (ROIs) spanning both cortical and subcortical areas.
34-1	4817-4820	ROI	_
34-2	4821-4830	selection	_
34-3	4831-4833	We	_
34-4	4834-4839	chose	_
34-5	4840-4842	to	_
34-6	4843-4846	use	_
34-7	4847-4848	a	_
34-8	4849-4852	set	_
34-9	4853-4855	of	_
34-10	4856-4859	283	_
34-11	4860-4867	regions	_
34-12	4868-4870	of	_
34-13	4871-4879	interest	_
34-14	4880-4881	(	_
34-15	4882-4886	ROIs	_
34-16	4887-4888	)	_
34-17	4889-4897	spanning	_
34-18	4898-4902	both	_
34-19	4903-4911	cortical	_
34-20	4912-4915	and	_
34-21	4916-4927	subcortical	_
34-22	4928-4933	areas	_
34-23	4934-4935	.	_

Text=These ROIs are an extended version of a previously generated parcellation based on meta-analysis over a range of tasks that resulted in 264 ROIs of putative functional relevance.
35-1	4936-4941	These	_
35-2	4942-4946	ROIs	_
35-3	4947-4950	are	_
35-4	4951-4953	an	_
35-5	4954-4962	extended	_
35-6	4963-4970	version	_
35-7	4971-4973	of	_
35-8	4974-4975	a	_
35-9	4976-4986	previously	_
35-10	4987-4996	generated	_
35-11	4997-5009	parcellation	_
35-12	5010-5015	based	_
35-13	5016-5018	on	_
35-14	5019-5032	meta-analysis	_
35-15	5033-5037	over	_
35-16	5038-5039	a	_
35-17	5040-5045	range	_
35-18	5046-5048	of	_
35-19	5049-5054	tasks	_
35-20	5055-5059	that	_
35-21	5060-5068	resulted	_
35-22	5069-5071	in	_
35-23	5072-5075	264	_
35-24	5076-5080	ROIs	_
35-25	5081-5083	of	_
35-26	5084-5092	putative	_
35-27	5093-5103	functional	_
35-28	5104-5113	relevance	_
35-29	5114-5115	.	_

Text=Each ROI is a 5 mm sphere around a voxel of peak significant activity during performance of tasks such as button-pressing, reading, and memory retrieval.
36-1	5116-5120	Each	_
36-2	5121-5124	ROI	_
36-3	5125-5127	is	_
36-4	5128-5129	a	_
36-5	5130-5131	5	_
36-6	5132-5134	mm	_
36-7	5135-5141	sphere	_
36-8	5142-5148	around	_
36-9	5149-5150	a	_
36-10	5151-5156	voxel	_
36-11	5157-5159	of	_
36-12	5160-5164	peak	_
36-13	5165-5176	significant	_
36-14	5177-5185	activity	_
36-15	5186-5192	during	_
36-16	5193-5204	performance	_
36-17	5205-5207	of	_
36-18	5208-5213	tasks	_
36-19	5214-5218	such	_
36-20	5219-5221	as	_
36-21	5222-5237	button-pressing	_
36-22	5238-5239	,	_
36-23	5240-5247	reading	_
36-24	5248-5249	,	_
36-25	5250-5253	and	_
36-26	5254-5260	memory	_
36-27	5261-5270	retrieval	_
36-28	5271-5272	.	_

Text=Bilateral regions in the brainstem, basal forebrain, hippocampus, amygdala, and putamen make up the additional 19 ROIs.
37-1	5273-5282	Bilateral	_
37-2	5283-5290	regions	_
37-3	5291-5293	in	_
37-4	5294-5297	the	_
37-5	5298-5307	brainstem	_
37-6	5308-5309	,	_
37-7	5310-5315	basal	_
37-8	5316-5325	forebrain	_
37-9	5326-5327	,	_
37-10	5328-5339	hippocampus	_
37-11	5340-5341	,	_
37-12	5342-5350	amygdala	_
37-13	5351-5352	,	_
37-14	5353-5356	and	_
37-15	5357-5364	putamen	_
37-16	5365-5369	make	_
37-17	5370-5372	up	_
37-18	5373-5376	the	_
37-19	5377-5387	additional	_
37-20	5388-5390	19	_
37-21	5391-5395	ROIs	_
37-22	5396-5397	.	_

Text=For each subject, average time series were extracted for each ROI over the 5 mm spheres.
38-1	5398-5401	For	_
38-2	5402-5406	each	_
38-3	5407-5414	subject	_
38-4	5415-5416	,	_
38-5	5417-5424	average	_
38-6	5425-5429	time	_
38-7	5430-5436	series	_
38-8	5437-5441	were	_
38-9	5442-5451	extracted	_
38-10	5452-5455	for	_
38-11	5456-5460	each	_
38-12	5461-5464	ROI	_
38-13	5465-5469	over	_
38-14	5470-5473	the	_
38-15	5474-5475	5	_
38-16	5476-5478	mm	_
38-17	5479-5486	spheres	_
38-18	5487-5488	.	_

Text=Data sets were matched for number of time points to the COBRE SZ data set by randomly selecting a start point that resulted in 120 consecutive scans.
39-1	5489-5493	Data	_
39-2	5494-5498	sets	_
39-3	5499-5503	were	_
39-4	5504-5511	matched	_
39-5	5512-5515	for	_
39-6	5516-5522	number	_
39-7	5523-5525	of	_
39-8	5526-5530	time	_
39-9	5531-5537	points	_
39-10	5538-5540	to	_
39-11	5541-5544	the	_
39-12	5545-5550	COBRE	_
39-13	5551-5553	SZ	_
39-14	5554-5558	data	_
39-15	5559-5562	set	_
39-16	5563-5565	by	_
39-17	5566-5574	randomly	_
39-18	5575-5584	selecting	_
39-19	5585-5586	a	_
39-20	5587-5592	start	_
39-21	5593-5598	point	_
39-22	5599-5603	that	_
39-23	5604-5612	resulted	_
39-24	5613-5615	in	_
39-25	5616-5619	120	_
39-26	5620-5631	consecutive	_
39-27	5632-5637	scans	_
39-28	5638-5639	.	_

Text=Connectivity matrix graph model generation There are a number of approaches to define functional relationships between brain areas.
40-1	5640-5652	Connectivity	_
40-2	5653-5659	matrix	_
40-3	5660-5665	graph	_
40-4	5666-5671	model	_
40-5	5672-5682	generation	_
40-6	5683-5688	There	_
40-7	5689-5692	are	_
40-8	5693-5694	a	_
40-9	5695-5701	number	_
40-10	5702-5704	of	_
40-11	5705-5715	approaches	_
40-12	5716-5718	to	_
40-13	5719-5725	define	_
40-14	5726-5736	functional	_
40-15	5737-5750	relationships	_
40-16	5751-5758	between	_
40-17	5759-5764	brain	_
40-18	5765-5770	areas	_
40-19	5771-5772	.	_

Text=One common approach is functional connectivity, which refers to temporal correlations signal intensity across brain regions.
41-1	5773-5776	One	_
41-2	5777-5783	common	_
41-3	5784-5792	approach	_
41-4	5793-5795	is	_
41-5	5796-5806	functional	_
41-6	5807-5819	connectivity	_
41-7	5820-5821	,	_
41-8	5822-5827	which	_
41-9	5828-5834	refers	_
41-10	5835-5837	to	_
41-11	5838-5846	temporal	_
41-12	5847-5859	correlations	_
41-13	5860-5866	signal	_
41-14	5867-5876	intensity	_
41-15	5877-5883	across	_
41-16	5884-5889	brain	_
41-17	5890-5897	regions	_
41-18	5898-5899	.	_

Text=In this study, we utilize a Bayesian approach to determine effective connectivity between brain areas.
42-1	5900-5902	In	_
42-2	5903-5907	this	_
42-3	5908-5913	study	_
42-4	5914-5915	,	_
42-5	5916-5918	we	_
42-6	5919-5926	utilize	_
42-7	5927-5928	a	_
42-8	5929-5937	Bayesian	_
42-9	5938-5946	approach	_
42-10	5947-5949	to	_
42-11	5950-5959	determine	_
42-12	5960-5969	effective	_
42-13	5970-5982	connectivity	_
42-14	5983-5990	between	_
42-15	5991-5996	brain	_
42-16	5997-6002	areas	_
42-17	6003-6004	.	_

Text=Effective connectivity is a measure of the influence brain regions exert over each other over time.
43-1	6005-6014	Effective	_
43-2	6015-6027	connectivity	_
43-3	6028-6030	is	_
43-4	6031-6032	a	_
43-5	6033-6040	measure	_
43-6	6041-6043	of	_
43-7	6044-6047	the	_
43-8	6048-6057	influence	_
43-9	6058-6063	brain	_
43-10	6064-6071	regions	_
43-11	6072-6077	exert	_
43-12	6078-6082	over	_
43-13	6083-6087	each	_
43-14	6088-6093	other	_
43-15	6094-6098	over	_
43-16	6099-6103	time	_
43-17	6104-6105	.	_

Text=Using Bayes Nets to determine effective connectivity offers some advantage over functional connectivity measures in that they are less sensitive to motion artifacts.
44-1	6106-6111	Using	_
44-2	6112-6117	Bayes	_
44-3	6118-6122	Nets	_
44-4	6123-6125	to	_
44-5	6126-6135	determine	_
44-6	6136-6145	effective	_
44-7	6146-6158	connectivity	_
44-8	6159-6165	offers	_
44-9	6166-6170	some	_
44-10	6171-6180	advantage	_
44-11	6181-6185	over	_
44-12	6186-6196	functional	_
44-13	6197-6209	connectivity	_
44-14	6210-6218	measures	_
44-15	6219-6221	in	_
44-16	6222-6226	that	_
44-17	6227-6231	they	_
44-18	6232-6235	are	_
44-19	6236-6240	less	_
44-20	6241-6250	sensitive	_
44-21	6251-6253	to	_
44-22	6254-6260	motion	_
44-23	6261-6270	artifacts	_
44-24	6271-6272	.	_

Text=Whereas motion results in artificially altered correlation coefficients across the brain, the probabilistic determination of connections between variables in Bayesian models make them less susceptible to spurious connections resulting from motion artifacts.
45-1	6273-6280	Whereas	_
45-2	6281-6287	motion	_
45-3	6288-6295	results	_
45-4	6296-6298	in	_
45-5	6299-6311	artificially	_
45-6	6312-6319	altered	_
45-7	6320-6331	correlation	_
45-8	6332-6344	coefficients	_
45-9	6345-6351	across	_
45-10	6352-6355	the	_
45-11	6356-6361	brain	_
45-12	6362-6363	,	_
45-13	6364-6367	the	_
45-14	6368-6381	probabilistic	_
45-15	6382-6395	determination	_
45-16	6396-6398	of	_
45-17	6399-6410	connections	_
45-18	6411-6418	between	_
45-19	6419-6428	variables	_
45-20	6429-6431	in	_
45-21	6432-6440	Bayesian	_
45-22	6441-6447	models	_
45-23	6448-6452	make	_
45-24	6453-6457	them	_
45-25	6458-6462	less	_
45-26	6463-6474	susceptible	_
45-27	6475-6477	to	_
45-28	6478-6486	spurious	_
45-29	6487-6498	connections	_
45-30	6499-6508	resulting	_
45-31	6509-6513	from	_
45-32	6514-6520	motion	_
45-33	6521-6530	artifacts	_
45-34	6531-6532	.	_

Text=In this study, Bayesian network models were generated for each subject to represent the effective connectivity between ROIs.
46-1	6533-6535	In	_
46-2	6536-6540	this	_
46-3	6541-6546	study	_
46-4	6547-6548	,	_
46-5	6549-6557	Bayesian	_
46-6	6558-6565	network	_
46-7	6566-6572	models	_
46-8	6573-6577	were	_
46-9	6578-6587	generated	_
46-10	6588-6591	for	_
46-11	6592-6596	each	_
46-12	6597-6604	subject	_
46-13	6605-6607	to	_
46-14	6608-6617	represent	_
46-15	6618-6621	the	_
46-16	6622-6631	effective	_
46-17	6632-6644	connectivity	_
46-18	6645-6652	between	_
46-19	6653-6657	ROIs	_
46-20	6658-6659	.	_

Text=Bayesian network models are graphical models where variables (ROIs) are depicted as the nodes of the network and directed edges as the interactions between nodes.
47-1	6660-6668	Bayesian	_
47-2	6669-6676	network	_
47-3	6677-6683	models	_
47-4	6684-6687	are	_
47-5	6688-6697	graphical	_
47-6	6698-6704	models	_
47-7	6705-6710	where	_
47-8	6711-6720	variables	_
47-9	6721-6722	(	_
47-10	6723-6727	ROIs	_
47-11	6728-6729	)	_
47-12	6730-6733	are	_
47-13	6734-6742	depicted	_
47-14	6743-6745	as	_
47-15	6746-6749	the	_
47-16	6750-6755	nodes	_
47-17	6756-6758	of	_
47-18	6759-6762	the	_
47-19	6763-6770	network	_
47-20	6771-6774	and	_
47-21	6775-6783	directed	_
47-22	6784-6789	edges	_
47-23	6790-6792	as	_
47-24	6793-6796	the	_
47-25	6797-6809	interactions	_
47-26	6810-6817	between	_
47-27	6818-6823	nodes	_
47-28	6824-6825	.	_

Text=Connections between ROIs represent probabilistic dependencies among variables quantified by their conditional probability distributions.
48-1	6826-6837	Connections	_
48-2	6838-6845	between	_
48-3	6846-6850	ROIs	_
48-4	6851-6860	represent	_
48-5	6861-6874	probabilistic	_
48-6	6875-6887	dependencies	_
48-7	6888-6893	among	_
48-8	6894-6903	variables	_
48-9	6904-6914	quantified	_
48-10	6915-6917	by	_
48-11	6918-6923	their	_
48-12	6924-6935	conditional	_
48-13	6936-6947	probability	_
48-14	6948-6961	distributions	_
48-15	6962-6963	.	_

Text=The network structure expresses the joint probability distribution over all variables.
49-1	6964-6967	The	_
49-2	6968-6975	network	_
49-3	6976-6985	structure	_
49-4	6986-6995	expresses	_
49-5	6996-6999	the	_
49-6	7000-7005	joint	_
49-7	7006-7017	probability	_
49-8	7018-7030	distribution	_
49-9	7031-7035	over	_
49-10	7036-7039	all	_
49-11	7040-7049	variables	_
49-12	7050-7051	.	_

Text=The structure of a Bayesian network model representing the interactions between each of the ROIs over the scan duration is learned from the ROI time series data using a score-based hill-climbing greedy search algorithm as implemented in the R bnlearn package (https: //cran.r-project.org/web/packages/bnlearn/index.html).
50-1	7052-7055	The	_
50-2	7056-7065	structure	_
50-3	7066-7068	of	_
50-4	7069-7070	a	_
50-5	7071-7079	Bayesian	_
50-6	7080-7087	network	_
50-7	7088-7093	model	_
50-8	7094-7106	representing	_
50-9	7107-7110	the	_
50-10	7111-7123	interactions	_
50-11	7124-7131	between	_
50-12	7132-7136	each	_
50-13	7137-7139	of	_
50-14	7140-7143	the	_
50-15	7144-7148	ROIs	_
50-16	7149-7153	over	_
50-17	7154-7157	the	_
50-18	7158-7162	scan	_
50-19	7163-7171	duration	_
50-20	7172-7174	is	_
50-21	7175-7182	learned	_
50-22	7183-7187	from	_
50-23	7188-7191	the	_
50-24	7192-7195	ROI	_
50-25	7196-7200	time	_
50-26	7201-7207	series	_
50-27	7208-7212	data	_
50-28	7213-7218	using	_
50-29	7219-7220	a	_
50-30	7221-7232	score-based	_
50-31	7233-7246	hill-climbing	_
50-32	7247-7253	greedy	_
50-33	7254-7260	search	_
50-34	7261-7270	algorithm	_
50-35	7271-7273	as	_
50-36	7274-7285	implemented	_
50-37	7286-7288	in	_
50-38	7289-7292	the	_
50-39	7293-7294	R	_
50-40	7295-7302	bnlearn	_
50-41	7303-7310	package	_
50-42	7311-7312	(	_
50-43	7313-7318	https	_
50-44	7319-7320	:	_
50-45	7321-7373	//cran.r-project.org/web/packages/bnlearn/index.html	_
50-46	7374-7375	)	_
50-47	7376-7377	.	_

Text=Such algorithms have been benchmarked for use in fMRI data and have demonstrated excellent accuracy and stability over known network structures.
51-1	7378-7382	Such	_
51-2	7383-7393	algorithms	_
51-3	7394-7398	have	_
51-4	7399-7403	been	_
51-5	7404-7415	benchmarked	_
51-6	7416-7419	for	_
51-7	7420-7423	use	_
51-8	7424-7426	in	_
51-9	7427-7431	fMRI	_
51-10	7432-7436	data	_
51-11	7437-7440	and	_
51-12	7441-7445	have	_
51-13	7446-7458	demonstrated	_
51-14	7459-7468	excellent	_
51-15	7469-7477	accuracy	_
51-16	7478-7481	and	_
51-17	7482-7491	stability	_
51-18	7492-7496	over	_
51-19	7497-7502	known	_
51-20	7503-7510	network	_
51-21	7511-7521	structures	_
51-22	7522-7523	.	_

Text=Bayesian information criterion (BIC) scores measure the goodness of fit of the network structure based on the log-likelihood of the data given the network structure, while simultaneously penalizing the number of parameters in the model.
52-1	7524-7532	Bayesian	_
52-2	7533-7544	information	_
52-3	7545-7554	criterion	_
52-4	7555-7556	(	_
52-5	7557-7560	BIC	_
52-6	7561-7562	)	_
52-7	7563-7569	scores	_
52-8	7570-7577	measure	_
52-9	7578-7581	the	_
52-10	7582-7590	goodness	_
52-11	7591-7593	of	_
52-12	7594-7597	fit	_
52-13	7598-7600	of	_
52-14	7601-7604	the	_
52-15	7605-7612	network	_
52-16	7613-7622	structure	_
52-17	7623-7628	based	_
52-18	7629-7631	on	_
52-19	7632-7635	the	_
52-20	7636-7650	log-likelihood	_
52-21	7651-7653	of	_
52-22	7654-7657	the	_
52-23	7658-7662	data	_
52-24	7663-7668	given	_
52-25	7669-7672	the	_
52-26	7673-7680	network	_
52-27	7681-7690	structure	_
52-28	7691-7692	,	_
52-29	7693-7698	while	_
52-30	7699-7713	simultaneously	_
52-31	7714-7724	penalizing	_
52-32	7725-7728	the	_
52-33	7729-7735	number	_
52-34	7736-7738	of	_
52-35	7739-7749	parameters	_
52-36	7750-7752	in	_
52-37	7753-7756	the	_
52-38	7757-7762	model	_
52-39	7763-7764	.	_

Text== maximized likelihood function of the model M over the observed data x, and parameter values θ n = number of data points k = number of parameters to be estimated.
53-1	7765-7766	=	_
53-2	7767-7776	maximized	_
53-3	7777-7787	likelihood	_
53-4	7788-7796	function	_
53-5	7797-7799	of	_
53-6	7800-7803	the	_
53-7	7804-7809	model	_
53-8	7810-7811	M	_
53-9	7812-7816	over	_
53-10	7817-7820	the	_
53-11	7821-7829	observed	_
53-12	7830-7834	data	_
53-13	7835-7836	x	_
53-14	7837-7838	,	_
53-15	7839-7842	and	_
53-16	7843-7852	parameter	_
53-17	7853-7859	values	_
53-18	7860-7861	θ	_
53-19	7862-7863	n	_
53-20	7864-7865	=	_
53-21	7866-7872	number	_
53-22	7873-7875	of	_
53-23	7876-7880	data	_
53-24	7881-7887	points	_
53-25	7888-7889	k	_
53-26	7890-7891	=	_
53-27	7892-7898	number	_
53-28	7899-7901	of	_
53-29	7902-7912	parameters	_
53-30	7913-7915	to	_
53-31	7916-7918	be	_
53-32	7919-7928	estimated	_
53-33	7929-7930	.	_

Text=As the number of parameters k in the model increases the BIC score also increases; lower BIC scores are considered better models.
54-1	7931-7933	As	_
54-2	7934-7937	the	_
54-3	7938-7944	number	_
54-4	7945-7947	of	_
54-5	7948-7958	parameters	_
54-6	7959-7960	k	_
54-7	7961-7963	in	_
54-8	7964-7967	the	_
54-9	7968-7973	model	_
54-10	7974-7983	increases	_
54-11	7984-7987	the	_
54-12	7988-7991	BIC	_
54-13	7992-7997	score	_
54-14	7998-8002	also	_
54-15	8003-8012	increases	_
54-16	8013-8014	;	_
54-17	8015-8020	lower	_
54-18	8021-8024	BIC	_
54-19	8025-8031	scores	_
54-20	8032-8035	are	_
54-21	8036-8046	considered	_
54-22	8047-8053	better	_
54-23	8054-8060	models	_
54-24	8061-8062	.	_

Text=In this way, the number of parameters in the model is constrained.
55-1	8063-8065	In	_
55-2	8066-8070	this	_
55-3	8071-8074	way	_
55-4	8075-8076	,	_
55-5	8077-8080	the	_
55-6	8081-8087	number	_
55-7	8088-8090	of	_
55-8	8091-8101	parameters	_
55-9	8102-8104	in	_
55-10	8105-8108	the	_
55-11	8109-8114	model	_
55-12	8115-8117	is	_
55-13	8118-8129	constrained	_
55-14	8130-8131	.	_

Text=Edges are added to the model individually and a new BIC score is calculated to determine whether the additional variable improves the fit.
56-1	8132-8137	Edges	_
56-2	8138-8141	are	_
56-3	8142-8147	added	_
56-4	8148-8150	to	_
56-5	8151-8154	the	_
56-6	8155-8160	model	_
56-7	8161-8173	individually	_
56-8	8174-8177	and	_
56-9	8178-8179	a	_
56-10	8180-8183	new	_
56-11	8184-8187	BIC	_
56-12	8188-8193	score	_
56-13	8194-8196	is	_
56-14	8197-8207	calculated	_
56-15	8208-8210	to	_
56-16	8211-8220	determine	_
56-17	8221-8228	whether	_
56-18	8229-8232	the	_
56-19	8233-8243	additional	_
56-20	8244-8252	variable	_
56-21	8253-8261	improves	_
56-22	8262-8265	the	_
56-23	8266-8269	fit	_
56-24	8270-8271	.	_

Text=The search procedure concludes when the fit is not further improved (the BIC score is not reduced) by inclusion of new edge parameters.
57-1	8272-8275	The	_
57-2	8276-8282	search	_
57-3	8283-8292	procedure	_
57-4	8293-8302	concludes	_
57-5	8303-8307	when	_
57-6	8308-8311	the	_
57-7	8312-8315	fit	_
57-8	8316-8318	is	_
57-9	8319-8322	not	_
57-10	8323-8330	further	_
57-11	8331-8339	improved	_
57-12	8340-8341	(	_
57-13	8342-8345	the	_
57-14	8346-8349	BIC	_
57-15	8350-8355	score	_
57-16	8356-8358	is	_
57-17	8359-8362	not	_
57-18	8363-8370	reduced	_
57-19	8371-8372	)	_
57-20	8373-8375	by	_
57-21	8376-8385	inclusion	_
57-22	8386-8388	of	_
57-23	8389-8392	new	_
57-24	8393-8397	edge	_
57-25	8398-8408	parameters	_
57-26	8409-8410	.	_

Text=The number of ROIs in our feature set was 283, resulting in 80,089 (283 × 283) possible edges or features.
58-1	8411-8414	The	_
58-2	8415-8421	number	_
58-3	8422-8424	of	_
58-4	8425-8429	ROIs	_
58-5	8430-8432	in	_
58-6	8433-8436	our	_
58-7	8437-8444	feature	_
58-8	8445-8448	set	_
58-9	8449-8452	was	_
58-10	8453-8456	283	_
58-11	8457-8458	,	_
58-12	8459-8468	resulting	_
58-13	8469-8471	in	_
58-14	8472-8478	80,089	_
58-15	8479-8480	(	_
58-16	8481-8484	283	_
58-17	8485-8486	×	_
58-18	8487-8490	283	_
58-19	8491-8492	)	_
58-20	8493-8501	possible	_
58-21	8502-8507	edges	_
58-22	8508-8510	or	_
58-23	8511-8519	features	_
58-24	8520-8521	.	_

Text=Therefore this is the feature space that is searched during the learning procedure.
59-1	8522-8531	Therefore	_
59-2	8532-8536	this	_
59-3	8537-8539	is	_
59-4	8540-8543	the	_
59-5	8544-8551	feature	_
59-6	8552-8557	space	_
59-7	8558-8562	that	_
59-8	8563-8565	is	_
59-9	8566-8574	searched	_
59-10	8575-8581	during	_
59-11	8582-8585	the	_
59-12	8586-8594	learning	_
59-13	8595-8604	procedure	_
59-14	8605-8606	.	_

Text=Once the graph structure is found, edge weights are determined as linear regression coefficients, resulting in a weighted connectivity matrix for each subject.
60-1	8607-8611	Once	_
60-2	8612-8615	the	_
60-3	8616-8621	graph	_
60-4	8622-8631	structure	_
60-5	8632-8634	is	_
60-6	8635-8640	found	_
60-7	8641-8642	,	_
60-8	8643-8647	edge	_
60-9	8648-8655	weights	_
60-10	8656-8659	are	_
60-11	8660-8670	determined	_
60-12	8671-8673	as	_
60-13	8674-8680	linear	_
60-14	8681-8691	regression	_
60-15	8692-8704	coefficients	_
60-16	8705-8706	,	_
60-17	8707-8716	resulting	_
60-18	8717-8719	in	_
60-19	8720-8721	a	_
60-20	8722-8730	weighted	_
60-21	8731-8743	connectivity	_
60-22	8744-8750	matrix	_
60-23	8751-8754	for	_
60-24	8755-8759	each	_
60-25	8760-8767	subject	_
60-26	8768-8769	.	_

Text=These weights were then normalized by subject by z-scoring over the non-zero model edge weights in order to preserve the relationships between variables and to facilitate comparison across subjects and data centers.
61-1	8770-8775	These	_
61-2	8776-8783	weights	_
61-3	8784-8788	were	_
61-4	8789-8793	then	_
61-5	8794-8804	normalized	_
61-6	8805-8807	by	_
61-7	8808-8815	subject	_
61-8	8816-8818	by	_
61-9	8819-8828	z-scoring	_
61-10	8829-8833	over	_
61-11	8834-8837	the	_
61-12	8838-8846	non-zero	_
61-13	8847-8852	model	_
61-14	8853-8857	edge	_
61-15	8858-8865	weights	_
61-16	8866-8868	in	_
61-17	8869-8874	order	_
61-18	8875-8877	to	_
61-19	8878-8886	preserve	_
61-20	8887-8890	the	_
61-21	8891-8904	relationships	_
61-22	8905-8912	between	_
61-23	8913-8922	variables	_
61-24	8923-8926	and	_
61-25	8927-8929	to	_
61-26	8930-8940	facilitate	_
61-27	8941-8951	comparison	_
61-28	8952-8958	across	_
61-29	8959-8967	subjects	_
61-30	8968-8971	and	_
61-31	8972-8976	data	_
61-32	8977-8984	centers	_
61-33	8985-8986	.	_

Text=Identifying relevant discriminatory features A linear support vector machine (SVM) was used to classify between schizophrenic patients and controls based on each subject's weighted connectivity matrix.
62-1	8987-8998	Identifying	_
62-2	8999-9007	relevant	_
62-3	9008-9022	discriminatory	_
62-4	9023-9031	features	_
62-5	9032-9033	A	_
62-6	9034-9040	linear	_
62-7	9041-9048	support	_
62-8	9049-9055	vector	_
62-9	9056-9063	machine	_
62-10	9064-9065	(	_
62-11	9066-9069	SVM	_
62-12	9070-9071	)	_
62-13	9072-9075	was	_
62-14	9076-9080	used	_
62-15	9081-9083	to	_
62-16	9084-9092	classify	_
62-17	9093-9100	between	_
62-18	9101-9114	schizophrenic	_
62-19	9115-9123	patients	_
62-20	9124-9127	and	_
62-21	9128-9136	controls	_
62-22	9137-9142	based	_
62-23	9143-9145	on	_
62-24	9146-9150	each	_
62-25	9151-9158	subject	_
62-26	9159-9161	's	_
62-27	9162-9170	weighted	_
62-28	9171-9183	connectivity	_
62-29	9184-9190	matrix	_
62-30	9191-9192	.	_

Text=An SVM is a supervised multivariate classification method that treats each of the features, or edges, as a point in a high dimensional space.
63-1	9193-9195	An	_
63-2	9196-9199	SVM	_
63-3	9200-9202	is	_
63-4	9203-9204	a	_
63-5	9205-9215	supervised	_
63-6	9216-9228	multivariate	_
63-7	9229-9243	classification	_
63-8	9244-9250	method	_
63-9	9251-9255	that	_
63-10	9256-9262	treats	_
63-11	9263-9267	each	_
63-12	9268-9270	of	_
63-13	9271-9274	the	_
63-14	9275-9283	features	_
63-15	9284-9285	,	_
63-16	9286-9288	or	_
63-17	9289-9294	edges	_
63-18	9295-9296	,	_
63-19	9297-9299	as	_
63-20	9300-9301	a	_
63-21	9302-9307	point	_
63-22	9308-9310	in	_
63-23	9311-9312	a	_
63-24	9313-9317	high	_
63-25	9318-9329	dimensional	_
63-26	9330-9335	space	_
63-27	9336-9337	.	_

Text=Training of an SVM results in a set of support vectors (points in multidimensional feature-space) that represent the boundary between classes.
64-1	9338-9346	Training	_
64-2	9347-9349	of	_
64-3	9350-9352	an	_
64-4	9353-9356	SVM	_
64-5	9357-9364	results	_
64-6	9365-9367	in	_
64-7	9368-9369	a	_
64-8	9370-9373	set	_
64-9	9374-9376	of	_
64-10	9377-9384	support	_
64-11	9385-9392	vectors	_
64-12	9393-9394	(	_
64-13	9395-9401	points	_
64-14	9402-9404	in	_
64-15	9405-9421	multidimensional	_
64-16	9422-9435	feature-space	_
64-17	9436-9437	)	_
64-18	9438-9442	that	_
64-19	9443-9452	represent	_
64-20	9453-9456	the	_
64-21	9457-9465	boundary	_
64-22	9466-9473	between	_
64-23	9474-9481	classes	_
64-24	9482-9483	.	_

Text=Because the support vectors are at the boundary between classes, they are not useful in determining features that are most indicative of each class.
65-1	9484-9491	Because	_
65-2	9492-9495	the	_
65-3	9496-9503	support	_
65-4	9504-9511	vectors	_
65-5	9512-9515	are	_
65-6	9516-9518	at	_
65-7	9519-9522	the	_
65-8	9523-9531	boundary	_
65-9	9532-9539	between	_
65-10	9540-9547	classes	_
65-11	9548-9549	,	_
65-12	9550-9554	they	_
65-13	9555-9558	are	_
65-14	9559-9562	not	_
65-15	9563-9569	useful	_
65-16	9570-9572	in	_
65-17	9573-9584	determining	_
65-18	9585-9593	features	_
65-19	9594-9598	that	_
65-20	9599-9602	are	_
65-21	9603-9607	most	_
65-22	9608-9618	indicative	_
65-23	9619-9621	of	_
65-24	9622-9626	each	_
65-25	9627-9632	class	_
65-26	9633-9634	.	_

Text=We identify the most indicative features using recursive feature elimination (RFE).
66-1	9635-9637	We	_
66-2	9638-9646	identify	_
66-3	9647-9650	the	_
66-4	9651-9655	most	_
66-5	9656-9666	indicative	_
66-6	9667-9675	features	_
66-7	9676-9681	using	_
66-8	9682-9691	recursive	_
66-9	9692-9699	feature	_
66-10	9700-9711	elimination	_
66-11	9712-9713	(	_
66-12	9714-9717	RFE	_
66-13	9718-9719	)	_
66-14	9720-9721	.	_

Text=The basic principle of RFE is to initially include all edges in the model and to gradually exclude edges, that do not contribute in discriminating between the two classes.
67-1	9722-9725	The	_
67-2	9726-9731	basic	_
67-3	9732-9741	principle	_
67-4	9742-9744	of	_
67-5	9745-9748	RFE	_
67-6	9749-9751	is	_
67-7	9752-9754	to	_
67-8	9755-9764	initially	_
67-9	9765-9772	include	_
67-10	9773-9776	all	_
67-11	9777-9782	edges	_
67-12	9783-9785	in	_
67-13	9786-9789	the	_
67-14	9790-9795	model	_
67-15	9796-9799	and	_
67-16	9800-9802	to	_
67-17	9803-9812	gradually	_
67-18	9813-9820	exclude	_
67-19	9821-9826	edges	_
67-20	9827-9828	,	_
67-21	9829-9833	that	_
67-22	9834-9836	do	_
67-23	9837-9840	not	_
67-24	9841-9851	contribute	_
67-25	9852-9854	in	_
67-26	9855-9869	discriminating	_
67-27	9870-9877	between	_
67-28	9878-9881	the	_
67-29	9882-9885	two	_
67-30	9886-9893	classes	_
67-31	9894-9895	.	_

Text=This approach iteratively trains and tests the SVM, discarding the least important features at each iteration until a core set of features remain, having the highest discriminative power.
68-1	9896-9900	This	_
68-2	9901-9909	approach	_
68-3	9910-9921	iteratively	_
68-4	9922-9928	trains	_
68-5	9929-9932	and	_
68-6	9933-9938	tests	_
68-7	9939-9942	the	_
68-8	9943-9946	SVM	_
68-9	9947-9948	,	_
68-10	9949-9959	discarding	_
68-11	9960-9963	the	_
68-12	9964-9969	least	_
68-13	9970-9979	important	_
68-14	9980-9988	features	_
68-15	9989-9991	at	_
68-16	9992-9996	each	_
68-17	9997-10006	iteration	_
68-18	10007-10012	until	_
68-19	10013-10014	a	_
68-20	10015-10019	core	_
68-21	10020-10023	set	_
68-22	10024-10026	of	_
68-23	10027-10035	features	_
68-24	10036-10042	remain	_
68-25	10043-10044	,	_
68-26	10045-10051	having	_
68-27	10052-10055	the	_
68-28	10056-10063	highest	_
68-29	10064-10078	discriminative	_
68-30	10079-10084	power	_
68-31	10085-10086	.	_

Text=At each iteration, data from the training set is randomly sub-divided into training and testing sets consisting of 10% of the total number of subjects.
69-1	10087-10089	At	_
69-2	10090-10094	each	_
69-3	10095-10104	iteration	_
69-4	10105-10106	,	_
69-5	10107-10111	data	_
69-6	10112-10116	from	_
69-7	10117-10120	the	_
69-8	10121-10129	training	_
69-9	10130-10133	set	_
69-10	10134-10136	is	_
69-11	10137-10145	randomly	_
69-12	10146-10157	sub-divided	_
69-13	10158-10162	into	_
69-14	10163-10171	training	_
69-15	10172-10175	and	_
69-16	10176-10183	testing	_
69-17	10184-10188	sets	_
69-18	10189-10199	consisting	_
69-19	10200-10202	of	_
69-20	10203-10205	10	_
69-21	10206-10207	%	_
69-22	10208-10210	of	_
69-23	10211-10214	the	_
69-24	10215-10220	total	_
69-25	10221-10227	number	_
69-26	10228-10230	of	_
69-27	10231-10239	subjects	_
69-28	10240-10241	.	_

Text=After training, the least significant 10% of features are removed from the feature set.
70-1	10242-10247	After	_
70-2	10248-10256	training	_
70-3	10257-10258	,	_
70-4	10259-10262	the	_
70-5	10263-10268	least	_
70-6	10269-10280	significant	_
70-7	10281-10283	10	_
70-8	10284-10285	%	_
70-9	10286-10288	of	_
70-10	10289-10297	features	_
70-11	10298-10301	are	_
70-12	10302-10309	removed	_
70-13	10310-10314	from	_
70-14	10315-10318	the	_
70-15	10319-10326	feature	_
70-16	10327-10330	set	_
70-17	10331-10332	.	_

Text=Feature significance is based on the support vector model coefficients.
71-1	10333-10340	Feature	_
71-2	10341-10353	significance	_
71-3	10354-10356	is	_
71-4	10357-10362	based	_
71-5	10363-10365	on	_
71-6	10366-10369	the	_
71-7	10370-10377	support	_
71-8	10378-10384	vector	_
71-9	10385-10390	model	_
71-10	10391-10403	coefficients	_
71-11	10404-10405	.	_

Text=Classification accuracy on the held out 10% of subjects is recorded at each iteration.
72-1	10406-10420	Classification	_
72-2	10421-10429	accuracy	_
72-3	10430-10432	on	_
72-4	10433-10436	the	_
72-5	10437-10441	held	_
72-6	10442-10445	out	_
72-7	10446-10448	10	_
72-8	10449-10450	%	_
72-9	10451-10453	of	_
72-10	10454-10462	subjects	_
72-11	10463-10465	is	_
72-12	10466-10474	recorded	_
72-13	10475-10477	at	_
72-14	10478-10482	each	_
72-15	10483-10492	iteration	_
72-16	10493-10494	.	_

Text=A bootstrap procedure was implemented that repeats the RFE process 100 times.
73-1	10495-10496	A	_
73-2	10497-10506	bootstrap	_
73-3	10507-10516	procedure	_
73-4	10517-10520	was	_
73-5	10521-10532	implemented	_
73-6	10533-10537	that	_
73-7	10538-10545	repeats	_
73-8	10546-10549	the	_
73-9	10550-10553	RFE	_
73-10	10554-10561	process	_
73-11	10562-10565	100	_
73-12	10566-10571	times	_
73-13	10572-10573	.	_

Text=Accuracies are averaged over the 100 bootstrap samples.
74-1	10574-10584	Accuracies	_
74-2	10585-10588	are	_
74-3	10589-10597	averaged	_
74-4	10598-10602	over	_
74-5	10603-10606	the	_
74-6	10607-10610	100	_
74-7	10611-10620	bootstrap	_
74-8	10621-10628	samples	_
74-9	10629-10630	.	_

Text=The number of features to include in the final model was determined by choosing the number that yielded the highest classification accuracy on average over the 100 bootstrap samples.
75-1	10631-10634	The	_
75-2	10635-10641	number	_
75-3	10642-10644	of	_
75-4	10645-10653	features	_
75-5	10654-10656	to	_
75-6	10657-10664	include	_
75-7	10665-10667	in	_
75-8	10668-10671	the	_
75-9	10672-10677	final	_
75-10	10678-10683	model	_
75-11	10684-10687	was	_
75-12	10688-10698	determined	_
75-13	10699-10701	by	_
75-14	10702-10710	choosing	_
75-15	10711-10714	the	_
75-16	10715-10721	number	_
75-17	10722-10726	that	_
75-18	10727-10734	yielded	_
75-19	10735-10738	the	_
75-20	10739-10746	highest	_
75-21	10747-10761	classification	_
75-22	10762-10770	accuracy	_
75-23	10771-10773	on	_
75-24	10774-10781	average	_
75-25	10782-10786	over	_
75-26	10787-10790	the	_
75-27	10791-10794	100	_
75-28	10795-10804	bootstrap	_
75-29	10805-10812	samples	_
75-30	10813-10814	.	_

Text=Edge features were sorted according to the frequency (1–100) of their inclusion in the top feature set yielding highest accuracy.
76-1	10815-10819	Edge	_
76-2	10820-10828	features	_
76-3	10829-10833	were	_
76-4	10834-10840	sorted	_
76-5	10841-10850	according	_
76-6	10851-10853	to	_
76-7	10854-10857	the	_
76-8	10858-10867	frequency	_
76-9	10868-10869	(	_
76-10	10870-10875	1–100	_
76-11	10876-10877	)	_
76-12	10878-10880	of	_
76-13	10881-10886	their	_
76-14	10887-10896	inclusion	_
76-15	10897-10899	in	_
76-16	10900-10903	the	_
76-17	10904-10907	top	_
76-18	10908-10915	feature	_
76-19	10916-10919	set	_
76-20	10920-10928	yielding	_
76-21	10929-10936	highest	_
76-22	10937-10945	accuracy	_
76-23	10946-10947	.	_

Text=The RFE process was done separately and identically for both the SZ and ASD data sets, resulting in a separate set of distinguishing features for each patient population from that of healthy controls.
77-1	10948-10951	The	_
77-2	10952-10955	RFE	_
77-3	10956-10963	process	_
77-4	10964-10967	was	_
77-5	10968-10972	done	_
77-6	10973-10983	separately	_
77-7	10984-10987	and	_
77-8	10988-10999	identically	_
77-9	11000-11003	for	_
77-10	11004-11008	both	_
77-11	11009-11012	the	_
77-12	11013-11015	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
77-13	11016-11019	and	_
77-14	11020-11023	ASD	_
77-15	11024-11028	data	_
77-16	11029-11033	sets	_
77-17	11034-11035	,	_
77-18	11036-11045	resulting	_
77-19	11046-11048	in	_
77-20	11049-11050	a	_
77-21	11051-11059	separate	_
77-22	11060-11063	set	_
77-23	11064-11066	of	_
77-24	11067-11081	distinguishing	_
77-25	11082-11090	features	_
77-26	11091-11094	for	_
77-27	11095-11099	each	_
77-28	11100-11107	patient	_
77-29	11108-11118	population	_
77-30	11119-11123	from	_
77-31	11124-11128	that	_
77-32	11129-11131	of	_
77-33	11132-11139	healthy	_
77-34	11140-11148	controls	_
77-35	11149-11150	.	_

Text=A separate SVM model for SZ and ASD was then created using these features.
78-1	11151-11152	A	_
78-2	11153-11161	separate	_
78-3	11162-11165	SVM	_
78-4	11166-11171	model	_
78-5	11172-11175	for	_
78-6	11176-11178	SZ	_
78-7	11179-11182	and	_
78-8	11183-11186	ASD	_
78-9	11187-11190	was	_
78-10	11191-11195	then	_
78-11	11196-11203	created	_
78-12	11204-11209	using	_
78-13	11210-11215	these	_
78-14	11216-11224	features	_
78-15	11225-11226	.	_

Text=Cross validation on independent data Independent data sets, from a new cohort of subjects that were collected at different sites were used as testing cross validation sets.
79-1	11227-11232	Cross	_
79-2	11233-11243	validation	_
79-3	11244-11246	on	_
79-4	11247-11258	independent	_
79-5	11259-11263	data	_
79-6	11264-11275	Independent	_
79-7	11276-11280	data	_
79-8	11281-11285	sets	_
79-9	11286-11287	,	_
79-10	11288-11292	from	_
79-11	11293-11294	a	_
79-12	11295-11298	new	_
79-13	11299-11305	cohort	_
79-14	11306-11308	of	_
79-15	11309-11317	subjects	_
79-16	11318-11322	that	_
79-17	11323-11327	were	_
79-18	11328-11337	collected	_
79-19	11338-11340	at	_
79-20	11341-11350	different	_
79-21	11351-11356	sites	_
79-22	11357-11361	were	_
79-23	11362-11366	used	_
79-24	11367-11369	as	_
79-25	11370-11377	testing	_
79-26	11378-11383	cross	_
79-27	11384-11394	validation	_
79-28	11395-11399	sets	_
79-29	11400-11401	.	_

Text=The SVM models generated from the features identified through the RFE procedure, were used to predict group membership of the testing cross validation data sets.
80-1	11402-11405	The	_
80-2	11406-11409	SVM	_
80-3	11410-11416	models	_
80-4	11417-11426	generated	_
80-5	11427-11431	from	_
80-6	11432-11435	the	_
80-7	11436-11444	features	_
80-8	11445-11455	identified	_
80-9	11456-11463	through	_
80-10	11464-11467	the	_
80-11	11468-11471	RFE	_
80-12	11472-11481	procedure	_
80-13	11482-11483	,	_
80-14	11484-11488	were	_
80-15	11489-11493	used	_
80-16	11494-11496	to	_
80-17	11497-11504	predict	_
80-18	11505-11510	group	_
80-19	11511-11521	membership	_
80-20	11522-11524	of	_
80-21	11525-11528	the	_
80-22	11529-11536	testing	_
80-23	11537-11542	cross	_
80-24	11543-11553	validation	_
80-25	11554-11558	data	_
80-26	11559-11563	sets	_
80-27	11564-11565	.	_

Text=Each of the new data sets underwent identical preprocessing procedures as the original training cohorts.
81-1	11566-11570	Each	_
81-2	11571-11573	of	_
81-3	11574-11577	the	_
81-4	11578-11581	new	_
81-5	11582-11586	data	_
81-6	11587-11591	sets	_
81-7	11592-11601	underwent	_
81-8	11602-11611	identical	_
81-9	11612-11625	preprocessing	_
81-10	11626-11636	procedures	_
81-11	11637-11639	as	_
81-12	11640-11643	the	_
81-13	11644-11652	original	_
81-14	11653-11661	training	_
81-15	11662-11669	cohorts	_
81-16	11670-11671	.	_

Text=Their weighted edge matrices were used to determine how well our SVM models generalize.
82-1	11672-11677	Their	_
82-2	11678-11686	weighted	_
82-3	11687-11691	edge	_
82-4	11692-11700	matrices	_
82-5	11701-11705	were	_
82-6	11706-11710	used	_
82-7	11711-11713	to	_
82-8	11714-11723	determine	_
82-9	11724-11727	how	_
82-10	11728-11732	well	_
82-11	11733-11736	our	_
82-12	11737-11740	SVM	_
82-13	11741-11747	models	_
82-14	11748-11758	generalize	_
82-15	11759-11760	.	_

Text=We predicted the group membership (ASD vs control, SZ vs control) on these new subjects using the SVM models that were trained on the initial training cohort of subjects.
83-1	11761-11763	We	_
83-2	11764-11773	predicted	_
83-3	11774-11777	the	_
83-4	11778-11783	group	_
83-5	11784-11794	membership	_
83-6	11795-11796	(	_
83-7	11797-11800	ASD	_
83-8	11801-11803	vs	_
83-9	11804-11811	control	_
83-10	11812-11813	,	_
83-11	11814-11816	SZ	_
83-12	11817-11819	vs	_
83-13	11820-11827	control	_
83-14	11828-11829	)	_
83-15	11830-11832	on	_
83-16	11833-11838	these	_
83-17	11839-11842	new	_
83-18	11843-11851	subjects	_
83-19	11852-11857	using	_
83-20	11858-11861	the	_
83-21	11862-11865	SVM	_
83-22	11866-11872	models	_
83-23	11873-11877	that	_
83-24	11878-11882	were	_
83-25	11883-11890	trained	_
83-26	11891-11893	on	_
83-27	11894-11897	the	_
83-28	11898-11905	initial	_
83-29	11906-11914	training	_
83-30	11915-11921	cohort	_
83-31	11922-11924	of	_
83-32	11925-11933	subjects	_
83-33	11934-11935	.	_

Text=Cross-validation in this way, allows us to see how well our models generalize outside of the patient population on which it was trained and also ensures that classification accuracy is not driven by differences in age, scanning site or other potential cohort or procedural differences in subject groups.
84-1	11936-11952	Cross-validation	_
84-2	11953-11955	in	_
84-3	11956-11960	this	_
84-4	11961-11964	way	_
84-5	11965-11966	,	_
84-6	11967-11973	allows	_
84-7	11974-11976	us	_
84-8	11977-11979	to	_
84-9	11980-11983	see	_
84-10	11984-11987	how	_
84-11	11988-11992	well	_
84-12	11993-11996	our	_
84-13	11997-12003	models	_
84-14	12004-12014	generalize	_
84-15	12015-12022	outside	_
84-16	12023-12025	of	_
84-17	12026-12029	the	_
84-18	12030-12037	patient	_
84-19	12038-12048	population	_
84-20	12049-12051	on	_
84-21	12052-12057	which	_
84-22	12058-12060	it	_
84-23	12061-12064	was	_
84-24	12065-12072	trained	_
84-25	12073-12076	and	_
84-26	12077-12081	also	_
84-27	12082-12089	ensures	_
84-28	12090-12094	that	_
84-29	12095-12109	classification	_
84-30	12110-12118	accuracy	_
84-31	12119-12121	is	_
84-32	12122-12125	not	_
84-33	12126-12132	driven	_
84-34	12133-12135	by	_
84-35	12136-12147	differences	_
84-36	12148-12150	in	_
84-37	12151-12154	age	_
84-38	12155-12156	,	_
84-39	12157-12165	scanning	_
84-40	12166-12170	site	_
84-41	12171-12173	or	_
84-42	12174-12179	other	_
84-43	12180-12189	potential	_
84-44	12190-12196	cohort	_
84-45	12197-12199	or	_
84-46	12200-12210	procedural	_
84-47	12211-12222	differences	_
84-48	12223-12225	in	_
84-49	12226-12233	subject	_
84-50	12234-12240	groups	_
84-51	12241-12242	.	_

Text=Identifying common and disparate features of autism and schizophrenia To identify common and disparate features of ASD and SZ we formed a control group from a mixture of equal numbers of subjects from the control groups of the ASD and SZ data sets.
85-1	12243-12254	Identifying	_
85-2	12255-12261	common	_
85-3	12262-12265	and	_
85-4	12266-12275	disparate	_
85-5	12276-12284	features	_
85-6	12285-12287	of	_
85-7	12288-12294	autism	_
85-8	12295-12298	and	_
85-9	12299-12312	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
85-10	12313-12315	To	_
85-11	12316-12324	identify	_
85-12	12325-12331	common	_
85-13	12332-12335	and	_
85-14	12336-12345	disparate	_
85-15	12346-12354	features	_
85-16	12355-12357	of	_
85-17	12358-12361	ASD	http://maven.renci.org/NeuroBridge/neurobridge#Thing
85-18	12362-12365	and	_
85-19	12366-12368	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
85-20	12369-12371	we	_
85-21	12372-12378	formed	_
85-22	12379-12380	a	_
85-23	12381-12388	control	_
85-24	12389-12394	group	_
85-25	12395-12399	from	_
85-26	12400-12401	a	_
85-27	12402-12409	mixture	_
85-28	12410-12412	of	_
85-29	12413-12418	equal	_
85-30	12419-12426	numbers	_
85-31	12427-12429	of	_
85-32	12430-12438	subjects	_
85-33	12439-12443	from	_
85-34	12444-12447	the	_
85-35	12448-12455	control	_
85-36	12456-12462	groups	_
85-37	12463-12465	of	_
85-38	12466-12469	the	_
85-39	12470-12473	ASD	_
85-40	12474-12477	and	_
85-41	12478-12480	SZ	_
85-42	12481-12485	data	_
85-43	12486-12490	sets	_
85-44	12491-12492	.	_

Text=Using this control group during training avoids identifying features that could potentially distinguish the two data sets (SZ and ASD training sets) for reasons having nothing to do with the different patient population features.
86-1	12493-12498	Using	_
86-2	12499-12503	this	_
86-3	12504-12511	control	_
86-4	12512-12517	group	_
86-5	12518-12524	during	_
86-6	12525-12533	training	_
86-7	12534-12540	avoids	_
86-8	12541-12552	identifying	_
86-9	12553-12561	features	_
86-10	12562-12566	that	_
86-11	12567-12572	could	_
86-12	12573-12584	potentially	_
86-13	12585-12596	distinguish	_
86-14	12597-12600	the	_
86-15	12601-12604	two	_
86-16	12605-12609	data	_
86-17	12610-12614	sets	_
86-18	12615-12616	(	_
86-19	12617-12619	SZ	_
86-20	12620-12623	and	_
86-21	12624-12627	ASD	_
86-22	12628-12636	training	_
86-23	12637-12641	sets	_
86-24	12642-12643	)	_
86-25	12644-12647	for	_
86-26	12648-12655	reasons	_
86-27	12656-12662	having	_
86-28	12663-12670	nothing	_
86-29	12671-12673	to	_
86-30	12674-12676	do	_
86-31	12677-12681	with	_
86-32	12682-12685	the	_
86-33	12686-12695	different	_
86-34	12696-12703	patient	_
86-35	12704-12714	population	_
86-36	12715-12723	features	_
86-37	12724-12725	.	_

Text=That is, the hybrid control group is also drawn from samples across scanners.
87-1	12726-12730	That	_
87-2	12731-12733	is	_
87-3	12734-12735	,	_
87-4	12736-12739	the	_
87-5	12740-12746	hybrid	_
87-6	12747-12754	control	_
87-7	12755-12760	group	_
87-8	12761-12763	is	_
87-9	12764-12768	also	_
87-10	12769-12774	drawn	_
87-11	12775-12779	from	_
87-12	12780-12787	samples	_
87-13	12788-12794	across	_
87-14	12795-12803	scanners	_
87-15	12804-12805	.	_

Text=Therefore, the classification cannot be made solely on differences that may be present in data samples due to collection at different scanner sites.
88-1	12806-12815	Therefore	_
88-2	12816-12817	,	_
88-3	12818-12821	the	_
88-4	12822-12836	classification	_
88-5	12837-12840	can	_
88-6	12841-12844	not	_
88-7	12845-12847	be	_
88-8	12848-12852	made	_
88-9	12853-12859	solely	_
88-10	12860-12862	on	_
88-11	12863-12874	differences	_
88-12	12875-12879	that	_
88-13	12880-12883	may	_
88-14	12884-12886	be	_
88-15	12887-12894	present	_
88-16	12895-12897	in	_
88-17	12898-12902	data	_
88-18	12903-12910	samples	_
88-19	12911-12914	due	_
88-20	12915-12917	to	_
88-21	12918-12928	collection	_
88-22	12929-12931	at	_
88-23	12932-12941	different	_
88-24	12942-12949	scanner	_
88-25	12950-12955	sites	_
88-26	12956-12957	.	_

Text=RFE was performed separately for ASD and SZ against this common control group.
89-1	12958-12961	RFE	_
89-2	12962-12965	was	_
89-3	12966-12975	performed	_
89-4	12976-12986	separately	_
89-5	12987-12990	for	_
89-6	12991-12994	ASD	http://maven.renci.org/NeuroBridge/neurobridge#Thing
89-7	12995-12998	and	_
89-8	12999-13001	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
89-9	13002-13009	against	_
89-10	13010-13014	this	_
89-11	13015-13021	common	_
89-12	13022-13029	control	_
89-13	13030-13035	group	_
89-14	13036-13037	.	_

Text=Identified features were separated into common and divergent feature sets.
90-1	13038-13048	Identified	_
90-2	13049-13057	features	_
90-3	13058-13062	were	_
90-4	13063-13072	separated	_
90-5	13073-13077	into	_
90-6	13078-13084	common	_
90-7	13085-13088	and	_
90-8	13089-13098	divergent	_
90-9	13099-13106	feature	_
90-10	13107-13111	sets	_
90-11	13112-13113	.	_

Text=Common features were those identified by both the SZ and ASD RFE procedures against the common control; divergent features were the remaining SZ and ASD features combined.
91-1	13114-13120	Common	_
91-2	13121-13129	features	_
91-3	13130-13134	were	_
91-4	13135-13140	those	_
91-5	13141-13151	identified	_
91-6	13152-13154	by	_
91-7	13155-13159	both	_
91-8	13160-13163	the	_
91-9	13164-13166	SZ	_
91-10	13167-13170	and	_
91-11	13171-13174	ASD	_
91-12	13175-13178	RFE	_
91-13	13179-13189	procedures	_
91-14	13190-13197	against	_
91-15	13198-13201	the	_
91-16	13202-13208	common	_
91-17	13209-13216	control	_
91-18	13217-13218	;	_
91-19	13219-13228	divergent	_
91-20	13229-13237	features	_
91-21	13238-13242	were	_
91-22	13243-13246	the	_
91-23	13247-13256	remaining	_
91-24	13257-13259	SZ	_
91-25	13260-13263	and	_
91-26	13264-13267	ASD	_
91-27	13268-13276	features	_
91-28	13277-13285	combined	_
91-29	13286-13287	.	_

Text=Features were then divided into non-overlapping functional networks for the purpose of visualization using network definitions from a previously defined functional brain atlas.
92-1	13288-13296	Features	_
92-2	13297-13301	were	_
92-3	13302-13306	then	_
92-4	13307-13314	divided	_
92-5	13315-13319	into	_
92-6	13320-13335	non-overlapping	_
92-7	13336-13346	functional	_
92-8	13347-13355	networks	_
92-9	13356-13359	for	_
92-10	13360-13363	the	_
92-11	13364-13371	purpose	_
92-12	13372-13374	of	_
92-13	13375-13388	visualization	_
92-14	13389-13394	using	_
92-15	13395-13402	network	_
92-16	13403-13414	definitions	_
92-17	13415-13419	from	_
92-18	13420-13421	a	_
92-19	13422-13432	previously	_
92-20	13433-13440	defined	_
92-21	13441-13451	functional	_
92-22	13452-13457	brain	_
92-23	13458-13463	atlas	_
92-24	13464-13465	.	_

Text=ROIs were defined as belonging to a given network if they were spatially overlapping with the atlas network mask.
93-1	13466-13470	ROIs	_
93-2	13471-13475	were	_
93-3	13476-13483	defined	_
93-4	13484-13486	as	_
93-5	13487-13496	belonging	_
93-6	13497-13499	to	_
93-7	13500-13501	a	_
93-8	13502-13507	given	_
93-9	13508-13515	network	_
93-10	13516-13518	if	_
93-11	13519-13523	they	_
93-12	13524-13528	were	_
93-13	13529-13538	spatially	_
93-14	13539-13550	overlapping	_
93-15	13551-13555	with	_
93-16	13556-13559	the	_
93-17	13560-13565	atlas	_
93-18	13566-13573	network	_
93-19	13574-13578	mask	_
93-20	13579-13580	.	_

